| Comprehensive genomic characterization defines human glioblastoma genes and core pathways Cancer Genome Atlas Research Network Tissue source sites: Duke University ... Nature 455 (7216), 1061-1068, 2008 | 7412 | 2008 |
| Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses A Bhattacharjee, WG Richards, J Staunton, C Li, S Monti, P Vasa, C Ladd, ... Proceedings of the National Academy of Sciences 98 (24), 13790-13795, 2001 | 3114 | 2001 |
| Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data S Monti, P Tamayo, J Mesirov, T Golub Machine learning 52, 91-118, 2003 | 2289 | 2003 |
| Initial genome sequencing and analysis of multiple myeloma MA Chapman, MS Lawrence, JJ Keats, K Cibulskis, C Sougnez, ... Nature 471 (7339), 467-472, 2011 | 1713 | 2011 |
| Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes B Chapuy, C Stewart, AJ Dunford, J Kim, A Kamburov, RA Redd, ... Nature medicine 24 (5), 679-690, 2018 | 1593 | 2018 |
| Integrative analysis reveals selective 9p24. 1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and … MR Green, S Monti, SJ Rodig, P Juszczynski, T Currie, E O'Donnell, ... Blood, The Journal of the American Society of Hematology 116 (17), 3268-3277, 2010 | 1401 | 2010 |
| The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma KJ Savage, S Monti, JL Kutok, G Cattoretti, D Neuberg, L De Leval, ... Blood 102 (12), 3871-3879, 2003 | 1040 | 2003 |
| Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response S Monti, KJ Savage, JL Kutok, F Feuerhake, P Kurtin, M Mihm, B Wu, ... Blood 105 (5), 1851-1861, 2005 | 976 | 2005 |
| Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma B Chapuy, MR McKeown, CY Lin, S Monti, MGM Roemer, J Qi, PB Rahl, ... Cancer cell 24 (6), 777-790, 2013 | 823 | 2013 |
| Targetable genetic features of primary testicular and primary central nervous system lymphomas B Chapuy, MGM Roemer, C Stewart, Y Tan, RP Abo, L Zhang, AJ Dunford, ... Blood, The Journal of the American Society of Hematology 127 (7), 869-881, 2016 | 524 | 2016 |
| Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma P Caro, AU Kishan, E Norberg, IA Stanley, B Chapuy, SB Ficarro, K Polak, ... Cancer cell 22 (4), 547-560, 2012 | 516 | 2012 |
| Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells R Chiarle, Y Zhang, RL Frock, SM Lewis, B Molinie, YJ Ho, DR Myers, ... Cell 147 (1), 107-119, 2011 | 505 | 2011 |
| Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma L Pasqualucci, M Compagno, J Houldsworth, S Monti, A Grunn, ... The Journal of experimental medicine 203 (2), 311-317, 2006 | 489 | 2006 |
| SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma L Chen, S Monti, P Juszczynski, J Daley, W Chen, TE Witzig, ... Blood, The Journal of the American Society of Hematology 111 (4), 2230-2237, 2008 | 426 | 2008 |
| The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma P Juszczynski, J Ouyang, S Monti, SJ Rodig, K Takeyama, J Abramson, ... Proceedings of the National Academy of Sciences 104 (32), 13134-13139, 2007 | 393 | 2007 |
| Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts DN Hayes, S Monti, G Parmigiani, CB Gilks, K Naoki, A Bhattacharjee, ... Journal of Clinical Oncology 24 (31), 5079-5090, 2006 | 340 | 2006 |
| NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes F Feuerhake, JL Kutok, S Monti, W Chen, AS LaCasce, G Cattoretti, ... Blood 106 (4), 1392-1399, 2005 | 302 | 2005 |
| Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells CZ Chen, M Li, D de Graaf, S Monti, B Göttgens, MJ Sanchez, ES Lander, ... Proceedings of the National Academy of Sciences 99 (24), 15468-15473, 2002 | 232 | 2002 |
| Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma S Monti, B Chapuy, K Takeyama, SJ Rodig, Y Hao, KT Yeda, H Inguilizian, ... Cancer cell 22 (3), 359-372, 2012 | 230 | 2012 |
| SYK inhibition modulates distinct PI3K/AKT-dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas L Chen, S Monti, P Juszczynski, J Ouyang, B Chapuy, D Neuberg, ... Cancer cell 23 (6), 826-838, 2013 | 206 | 2013 |
